# Rani Therapeutics, LLC: Form D filings

Rani Therapeutics, LLC, a biotechnology company in San Jose, CA, filed 4 Form D notices with the SEC between 2015 and 2020. The latest, on November 16, 2020, reports $50 million sold of a $75 million offering to 2 investors.

Find out what Rani Therapeutics, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Rani%20Therapeutics%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Rani%20Therapeutics%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Frani-therapeutics-llc-1644130)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Rani%20Therapeutics%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Rani%20Therapeutics%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Frani-therapeutics-llc-1644130)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2051 RINGWOOD AVENUE, San Jose, CA, 95131
- Phone: (408) 457-3712
- Industry: Biotechnology
- Entity type: Limited Liability Company
- Incorporated in: California
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1644130

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 16, 2020 | New notice | $75,000,000 | $50,000,000 | $25,000,000 | 2 | Oct 30, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1644130/000164413020000001/0001644130-20-000001-index.htm) |
| Sep 13, 2017 | New notice | $126,450,000 | $38,663,952 | $87,786,048 | 12 | Aug 24, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1644130/000164413017000001/0001644130-17-000001-index.htm) |
| Jun 4, 2015 | New notice | $15,001,900 | $7,650,001 | $7,351,899 | 2 | May 22, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1644130/000164413015000002/0001644130-15-000002-index.htm) |
| Jun 4, 2015 | New notice | $52,272,000 | $15,486,363 | $36,785,637 | 10 | May 21, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1644130/000164413015000001/0001644130-15-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Svai Sanford | Executive Officer |  |
| Maulik Nanavaty | Director |  |
| Andrew Farquharson | Director |  |
| Mir Hashim | Executive Officer, Director |  |
| Mir Imran | Executive Officer, Director |  |
| Dennis Ausiello | Director |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026
- [Estuary Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/estuary-biotherapeutics-inc-2138862) $40.7 million · Oct 16, 2026
- [Renue Life Sciences, Inc.](https://specstream.ai/data/form-d/company/renue-life-sciences-inc-2158207) $250,000 · Oct 14, 2026
- [Tempest Therapeutics, Inc.](https://specstream.ai/data/form-d/company/tempest-therapeutics-inc-1544227) $7.5 million · Oct 14, 2026
- [Lionheart Health, Inc.](https://specstream.ai/data/form-d/company/lionheart-health-inc-2156758) $387,500 · Oct 7, 2026
- [Rakuten Medical, Inc.](https://specstream.ai/data/form-d/company/rakuten-medical-inc-1595215) $9 million · Oct 6, 2026
- [Zonaliz, Inc.](https://specstream.ai/data/form-d/company/zonaliz-inc-2157556) $2.5 million · Oct 5, 2026
- [Altay Therapeutics, Inc.](https://specstream.ai/data/form-d/company/altay-therapeutics-inc-2157551) $15.7 million · Oct 2, 2026
- [Sialia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/sialia-therapeutics-inc-2156754) $1.5 million · Sep 29, 2026
- [Vetmab Biosciences, Inc.](https://specstream.ai/data/form-d/company/vetmab-biosciences-inc-1932050) $11.4 million · Sep 29, 2026

[Every Form D from the week of Nov 16, 2020](https://specstream.ai/data/form-d/week/2020-11-16) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Rani Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).